Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Low Grade Serous Ovarian Cancer × Anastrozole × 90 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 28 Neoplasms 5 Neoplasm Metastasis 3 Carcinoma, Intraductal, Noninfiltrating 3 Neoplasms by Site 2 Breast Neoplasms, Male 2 Breast Diseases 2 Uterine Cervical Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Ovarian Neoplasms 1 Low Grade Serous Ovarian Cancer 1 Locoregional Recurrence 1 Hereditary Sensory and Autonomic Neuropathies 1 Head and Neck Neoplasms 1 Endometrial Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Lobular 1 Carcinoma, Ductal, Breast 1 Breast Carcinoma In Situ 1 Breast Cancer Metastatic 1 Breast Cancer Female 1 Anatomic Stage III Breast Cancer AJCC v8 1 Advanced Breast Carcinoma 1 Advanced Breast Cancer 1

Interventions

liposomal doxorubicin 1 defactinib 1 Paclitaxel 1 Letrozole 1 Anastrozole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06072781 2026-03-17

RAMP 301

Verastem, Inc.

Phase 3 Recruiting

Low Grade Serous Ovarian Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡